(Q53232555)

English

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

scientific article published on 27 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Massimo Roncalli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jean Charles Nault

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Luca Di Tommaso

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jessica Zucman-Rossi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Paulette Bioulac-Sage

6

object named as

Paulette Bioulac-Sage

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Julien Calderaro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Charles Balabaud

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Elie Serge Zafrani

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

0 references

publication date

27 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1983-1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123086%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Genetics of hepatobiliary carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Advanced precancerous lesions in the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Radiofrequency ablation of high-grade dysplastic nodules

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Identification of driver genes in hepatocellular carcinoma by exome sequencing

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Frequency of TERT promoter mutations in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Hepatocellular benign tumors-from molecular classification to personalized clinical care

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Liver precancerous lesions and hepatocellular carcinoma: the histology report.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Changing trends in malignant transformation of hepatocellular adenoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

21 January 2018

Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27372

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53232555&oldid=1976454486"